NASDAQ OMX

Datalliance Enhances Cloud-based Supply Chain Platform

Dela

Manufacturers of Consumer and Industrial Products gain Increased Replenishment Efficiency

CINCINNATI, July 19, 2017 (GLOBE NEWSWIRE) -- Datalliance's latest update to its cloud-based Vendor Managed Inventory (VMI) platform makes it easier for manufacturers of consumer or industrial products to manage inventory replenishment for retailers and distributors. These enhancements - driven by feedback from its global user base and Datalliance's vision for the future of VMI - focus on making the user-experience even more flexible and intuitive.

Because the Datalliance VMI platform is cloud-based, these upgrades are available for immediate use by Datalliance customers and their trading partners. Datalliance releases all platform-wide updates at no cost, and there's never a need to install or download software updates. This is the second of three major releases Datalliance plans for the year. Since Datalliance's founding, more than 50 releases have been delivered.

Highlights of enhancements in this release include:

  • Order Workbench: New generation order worksheet with layout and content refinements as well as personalization capabilities such as filtering, column pinning, dynamic sort, user-selected grid data, tabs and other ease-of-use enhancements that improve user productivity in this primary VMI planner interface.
  • Product Activity Handling: New generation user interface, process flow and resolution options for handling system-identified errors in trading partner activity reporting. Again, improving planner speed and productivity for daily tasks.
  • Event Management: Enhanced event details gives users access to more information, and personalized user-views enable even more productive "one-stop" promotion event management.
  • Master Item Management: Extended capabilities and enhanced user-interface enable more efficient management of product family rotations and transitions across multiple replenishment locations.

As with every release, a number of general technical and performance enhancements have been included to support overall system scalability, reliability and availability.

At its recent annual forum, Datalliance customers who had beta-tested some of the enhancements gave rave reviews. One user stated: "Datalliance is always doing things to further improve user productivity with process automation and user interface refinements. We always appreciate that, but they really took some big steps with this release - especially in the order worksheet where we do most of our daily work. Not only does it enable us to work faster, but it will also enable us to train new planners more quickly."

About Datalliance

Datalliance is the world's largest provider of technology and services to support collaborative replenishment programs such as Vendor Managed Inventory (VMI) and related approaches.  Delivered as a cloud-based platform backed by extensive customer care, Datalliance makes it easy for trading partners to establish inventory management relationships that increase sales and profits by fully aligning business objectives, increasing on-shelf availability, optimizing turns, and reducing supply chain costs.  Datalliance manages billions of dollars in orders, millions of SKUs, and tens of thousands of locations worldwide for leading companies in consumer and industrial markets. For more information about Datalliance, visit www.datalliance.com.

Contact: Brian Lindner, Datalliance
513-791-7272




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Datalliance via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II combination study with APR-246 at hematology congress17.6.2018 06:05Pressmeddelande

STOCKHOLM, June 17, 2018. Karolinska Development's portfolio company Aprea Therapeutics presents continued positive development for the candidate drug APR-246 in patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm. The presentation at EHA follows the positive results presented at the 2018 American Association of Cancer Research (AACR) Annual Meeting in Chicago in April. The results from the Phase Ib/II combination study with APR-246 and azacitidine show an overall response rate (ORR) of 100 per cent in 9 evaluable patients, with 8 patients achieving a complete response (CR) and 1 patient achieving a marrow complete response (mCR). Conclusive data on Median progression free survival (PFS) and overall survival (OS) have not yet been obtained in the study. Adverse Events (AEs) during the APR-246 monotherapy lead-in phase were all grade 1 or grade 2. No dose limiting toxicities have been experienced to date

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II combination study with APR-246 at hematology congress17.6.2018 06:05Pressmeddelande

STOCKHOLM, June 17, 2018. Karolinska Development's portfolio company Aprea Therapeutics presents continued positive development for the candidate drug APR-246 in patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm. The presentation at EHA follows the positive results presented at the 2018 American Association of Cancer Research (AACR) Annual Meeting in Chicago in April. The results from the Phase Ib/II combination study with APR-246 and azacitidine show an overall response rate (ORR) of 100 per cent in 9 evaluable patients, with 8 patients achieving a complete response (CR) and 1 patient achieving a marrow complete response (mCR). Conclusive data on Median progression free survival (PFS) and overall survival (OS) have not yet been obtained in the study. Adverse Events (AEs) during the APR-246 monotherapy lead-in phase were all grade 1 or grade 2. No dose limiting toxicities have been experienced to date

INVNT/IP: US Responds to Nation-sponsored Crown-jewel Intellectual Property Theft15.6.2018 23:34Pressmeddelande

US Announcement of Large-Scale Tariffs in Response to Chinese Crown-Jewel Intellectual Property Theft Lauded by IP Protection Consortium INVNT/IP SEATTLE, June 15, 2018 (GLOBE NEWSWIRE) -- The Trump administration today announced 25% tariffs on $50 billion in Chinese goods, representing the first time the United States government has marked sectors in US-China trade for retaliation as a response to theft of crown-jewel intellectual property. In a public statement, President Trump announced that the measures were targeted toward goods that "contain industrially significant technologies." US Trade Representative Robert Lighthizer applauded the move on Fox News, noting, "It's thorough. It's moderate. It's appropriate." In a further explanation of the move, he added, "What I want to do is make sure that we protect our technology here at home, that we stop cybertheft and forced technology transfer, and ultimately, remember: 'China 2025' is a $300 billion subsidy program. The United States h

Brookfield Asset Management Announces Results of Annual and Special Meeting of Shareholders15.6.2018 22:30Pressmeddelande

BROOKFIELD, NEWS, June 15, 2018 (GLOBE NEWSWIRE) -- Brookfield Asset Management Inc. (TSX:BAM.A) (NYSE:BAM) (Euronext:BAMA) today announced that at the company's annual and special meeting of shareholders held earlier today in Toronto, approximately 92% of Class A Limited Voting Shares ("Class A Shares") voted in favour of an advisory vote approving the company's approach to executive compensation. In addition, at the meeting all eight nominees proposed for election to the board of directors by holders of Class A Shares and all eight nominees proposed for election to the board of directors by the holder of Class B Limited Voting Shares ("Class B Shares") were elected. Detailed results of the vote for the election of directors are set out below. Management received the following proxies from holders of Class A Shares in regard to the election of the eight directors nominated by this shareholder class: Director Nominee Votes For % Votes Withheld % M. Elyse Allan 620,669,437 99.53 2,921,9

NEP Completes Acquisition of Telerecord15.6.2018 13:53Pressmeddelande

FLORENCE, Italy, June 15, 2018 (GLOBE NEWSWIRE) -- Today NEP Group, a leading outsourced technical production partner supporting premier content producers of live sports and entertainment, announced that it has completed its acquisition of Telerecord, an Italy-based provider of outside broadcast solutions. Telerecord, a local industry leader with strong client relationships, covers popular sporting events in Italy and throughout Southern Europe including football, ice hockey and bobsleigh. The deal further diversifies NEP's business and expands its reach in Europe by adding additional local resources and talent. As part of the deal, all Telerecord staff members will join NEP. Telerecord will be rebranded as NEP and will be part of NEP Italy, which is led by Sergio Cecchini, GM of NEP Italy, who joined NEP in May. Telerecord also brings a fleet of several outside broadcast trucks, sprinter vans and motorcycles to the NEP Worldwide Network to serve clients across Europe. "We couldn't be

Fortuna Reports Results of Annual General Meeting15.6.2018 11:00Pressmeddelande

VANCOUVER, British Columbia, June 15, 2018 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE:FSM) (TSX:FVI) hereby announces the voting results at the Company's annual general meeting held on June 14, 2018. A total of 108,538,241 common shares were represented at the meeting, being 68% of the Company's issued and outstanding shares. Shareholders voted in favour of all matters brought before the meeting including the appointment of auditors, the election of management's nominees as directors, and the ratification and approval of the Company's amended Advance Notice Policy. Detailed results of the votes on the election of directors are as follows: Director Votes For Votes Withheld Jorge Ganoza Durant Simon Ridgway Mario Szotlender David Farrell David Laing Alfredo Sillau Kylie Dickson 74,947,635 (97.4%) 63,448,600 (82.5%) 70,831,225 (92.1%) 74,816,864 (97.3%) 73,597,731 (95.7%) 75,716,342 (98.4%) 76,476,115 (99.4%) 1,930,230 (2.5%) 13,429,266 (17.4%) 6,046,640 (7.9%) 2,061,001 (2.7%) 3

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum